Code
F2018/IOF-ConcepTT/455
Duration
01 January 2019 → 31 March 2021
Funding
Regional and community funding: Industrial Research Fund
Promotor
Research disciplines
-
Medical and health sciences
- Vaccinology
Keywords
personalized medicine
B lymphocyte; B cell receptor
CRISPR/Cas9, T cell receptor, T lymphocyte, Antibodies, Engineered immunity
Genome editing
Immunoglobulin genes
Project description
Transferred Immunity by Gene Editing of Antigen Receptors (TIGEAR) could become a challenging technology that would completely change the current view of immunity, immunization and vaccination. The primary purpose of this ConcepTT application is to generate proof-of-concept data.